Comparison of PRF and Corticosteroids in Impacted Third Molar Surgery

NCT07742826 — Not applicable, Recruiting, 60 participants, Final International University

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Comparison of Postoperative Effects of PRF and Corticosteroid Treatments in Impacted Third Molar Surgery

RegistryNCT07742826
StatusRecruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: single, treatment
Enrollment60 (Estimated)
SponsorFinal International University (Other)
ConditionsImpacted Mandibular Third Molar Extraction, Impacted Lower Third Molar, Impacted Wisdom Tooth
InterventionsPlatelet-rich fibrin (PRF), Dexamethasone, Amoxicillin/Clavulanic Acid, Paracetamol, Chlorhexidine (Biological, drug)
Datesstart 2024-09-03, primary completion 2026-08-01 (estimated), completion 2026-08-01 (estimated), first posted 2026-08-03, last updated 2026-08-03
Locations1 site in Cyprus

Related Papers Related Patents Related Grants Related Experts
All trials for Impacted Mandibular Third Molar Extraction All trials for Impacted Lower Third Molar All trials of Platelet-rich fibrin (PRF) All trials of Dexamethasone

-Summary

This prospective, randomized interventional study aims to compare the postoperative effects of standard treatment (control), platelet-rich fibrin (PRF), and PRF combined with corticosteroid treatment in patients undergoing impacted mandibular third molar surgery. A total of 60 participants will be randomly assigned to one of three treatment groups according to the study protocol. Postoperative pain, facial swelling, and trismus will be evaluated on postoperative days 1, 2, 3, and 7. The findings of this study are expected to provide evidence regarding the effectiveness of PRF alone and PRF combined with corticosteroid treatment in reducing postoperative complications following impacted mandibular third molar surgery.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
Standard Postoperative Treatment (Control)Active comparatorDrug: Amoxicillin/Clavulanic Acid; Drug: Paracetamol; Drug: ChlorhexidineParticipants receive standard postoperative treatment following impacted mandibular third molar surgery, including amoxicillin/clavulanic acid (Augmentin), paracetamol, and chlorhexidine mouthwash. No platelet-rich fibrin (PRF) or corticosteroid is administered.
Platelet-Rich Fibrin (PRF)ExperimentalBiological: Platelet-rich fibrin (PRF); Drug: Amoxicillin/Clavulanic Acid; Drug: Paracetamol; Drug: ChlorhexidineParticipants receive platelet-rich fibrin (PRF) placed into the extraction socket in addition to standard postoperative treatment consisting of amoxicillin/clavulanic acid (Augmentin), paracetamol, and chlorhexidine mouthwash following impacted mandibular third molar surgery.
Platelet-Rich Fibrin Plus CorticosteroidExperimentalBiological: Platelet-rich fibrin (PRF); Drug: Dexamethasone; Drug: Amoxicillin/Clavulanic Acid; Drug: Paracetamol; Drug: ChlorhexidineParticipants receive platelet-rich fibrin (PRF) placement into the extraction socket followed by intramuscular corticosteroid administration, in addition to standard postoperative treatment consisting of amoxicillin/clavulanic acid (Augmentin), paracetamol, and chlorhexidine mouthwash following impacted mandibular third molar surgery.
  • Platelet-rich fibrin (PRF) (Biological): Autologous platelet-rich fibrin (PRF) prepared from the participant's venous blood by centrifugation at 3000 rpm for 10 minutes, and then placed into the extraction socket immediately after impacted mandibular third molar surgery.
  • Dexamethasone (Drug): Dexamethasone (8 mg/2 mL) administered as a single intramuscular injection immediately after impacted mandibular third molar surgery in addition to platelet-rich fibrin (PRF), according to the study protocol.
  • Amoxicillin/Clavulanic Acid (Drug): Amoxicillin/clavulanic acid administered postoperatively according to the study protocol.
  • Paracetamol (Drug): Paracetamol 500 mg tablets administered postoperatively for pain control according to the study protocol.
  • Chlorhexidine (Drug): Chlorhexidine mouthwash administered postoperatively according to the study protocol.

+Outcome measures

Primary outcomes

  • Postoperative Pain [Postoperative Days 1, 2, 3, and 7]: Postoperative pain assessed using a 10-cm Visual Analog Scale (VAS), where 0 indicates no pain and 10 indicates the worst pain imaginable.
  • Postoperative Swelling [Postoperative Days 1, 2, 3, and 7]: Postoperative facial swelling assessed using a flexible measuring tape by recording the linear distances from the tragus to the pogonion (chin point), the tragus to the corner of the mouth, and the lateral canthus of the eye to the angle of the mandible.
  • Trismus [Postoperative Days 1, 2, 3, and 7]: Trismus assessed by measuring the maximum interincisal mouth opening (mm) using a digital caliper.

+Eligibility

Sex: All, ages: 18 Years to any, accepts healthy volunteers

Inclusion Criteria:

* Patients aged 18 years and older.
* Patients with good general health
* Patients with complete clinical and radiographic examination (panoramic radiograph/CBCT if applicable)
* Patients willing and able to attend all postoperative follow-up visits

Exclusion Criteria:

* Patients with systemic diseases that may impair wound healing (e.g., uncontrolled diabetes, immunodeficiency).
* Pregnant or breastfeeding women.
* Patients with acute infection, abscess, or pericoronitis at the surgical site.
* Patients with a history of allergy or contraindication to corticosteroids, local anesthetics, or prescribed medications.
* Patients using corticosteroids, anticoagulants, immunosuppressive drugs, or bisphosphonates.
* Patients with bleeding disorders.
* Patients with previous radiotherapy to the head and neck region.
* Patients unable or unwilling to comply with the study protocol or attend follow-up visits.

+Locations (1)

FacilityCityCountryStatus
Final International University Faculty of DentistryNicosiaCyprusRecruiting

+Publications

  • Donmezer CM, Bilginaylar K. Comparison of the Postoperative Effects of Local Antibiotic versus Systemic Antibiotic with the Use of Platelet-Rich Fibrin on Impacted Mandibular Third Molar Surgery: A Randomized Split-Mouth Study. Biomed Res Int. 2021 Dec 2;2021:3040661. doi: 10.1155/2021/3040661. eCollection 2021. PMID 34901267
  • Koc O, Er N, Karaca C, Bilginaylar K. Comparison of the effects of submucosal hyaluronidase and dexamethasone on postoperative edema, pain, trismus, and infection following impacted third molar surgery. BMC Oral Health. 2024 Aug 30;24(1):1018. doi: 10.1186/s12903-024-04729-1. PMID 39215323